Martin J M, Veis D, Korsmeyer S J, Sugden B
McArdle Laboratory for Cancer Research, University of Wisconsin, Madison 53706.
J Virol. 1993 Sep;67(9):5269-78. doi: 10.1128/JVI.67.9.5269-5278.1993.
The stable expression of the Epstein-Barr virus (EBV) latent membrane protein (LMP) in certain EBV-negative Burkitt's lymphoma cell lines correlates with an increased expression of the oncogene Bcl-2 (S. Henderson, M. Rowe, C. Gregory, D. Croom-Carter, F. Wang, R. Longnecker, E. Kieff, and A. Rickinson, Cell 65:1107-1115, 1991). This finding is consistent with a model in which Bcl-2 contributes to the immortalization of B cells mediated by EBV. We therefore asked whether the expression of Bcl-2 protein correlates with the induction of three cellular phenotypes induced by or associated with LMP. The expression of Bcl-2 in primary B cells infected with the B95-8 strain of EBV varied between 1 and 1.8 times that in uninfected cells when 50% of the cells were infected, expressed LMP, and incorporated 20-fold more [3H]thymidine than did uninfected cells. This finding indicates that induced proliferation of these primary cells is not sufficient to induce Bcl-2. We found that BALB/c 3T3 cells and their derivatives transformed by LMP do not express Bcl-2 detectably. The expression of LMP at high levels in lymphoid cells is cytotoxic and correlates with an increased expression of Bcl-2 following stable selection for the introduced LMP gene; 2 days after transfection, control vector- and LMP-transfected populations, however, express equal levels of Bcl-2 protein. We also analyzed transient expression of LMP in an EBV-negative Burkitt's lymphoma cell line. Infection of BJAB cells with the B95-8 strain of EBV results in an increase in Bcl-2 expression with a time course similar to that of LMP expression, and LMP alone transiently induces an increase in Bcl-2 expression in these cells. We interpret these observations to indicate that increased expression of Bcl-2 is unlikely to contribute to the ability of EBV to immortalize primary B cells and that both the transformation of rodent cells and the cytotoxicity mediated by LMP are independent of Bcl-2.
爱泼斯坦-巴尔病毒(EBV)潜伏膜蛋白(LMP)在某些EBV阴性的伯基特淋巴瘤细胞系中的稳定表达与癌基因Bcl-2表达的增加相关(S. 亨德森、M. 罗、C. 格雷戈里、D. 克鲁姆-卡特、F. 王、R. 朗内克、E. 基夫和A. 里金森,《细胞》65:1107 - 1115,1991)。这一发现与一种模型相符,即Bcl-2有助于EBV介导的B细胞永生化。因此,我们询问Bcl-2蛋白的表达是否与LMP诱导或与之相关的三种细胞表型的诱导有关。当50%的细胞被感染、表达LMP并比未感染细胞多掺入20倍的[³H]胸腺嘧啶核苷时,用EBV的B95 - 8株感染的原代B细胞中Bcl-2的表达比未感染细胞高1至1.8倍。这一发现表明这些原代细胞的诱导增殖不足以诱导Bcl-2。我们发现被LMP转化的BALB/c 3T3细胞及其衍生物未检测到Bcl-2的表达。在淋巴细胞中高水平表达LMP具有细胞毒性,并且在对导入的LMP基因进行稳定选择后与Bcl-2表达的增加相关;然而,转染后2天,对照载体转染群体和LMP转染群体表达的Bcl-2蛋白水平相等。我们还分析了LMP在EBV阴性的伯基特淋巴瘤细胞系中的瞬时表达。用EBV的B95 - 8株感染BJAB细胞导致Bcl-2表达增加,其时间进程与LMP表达相似,并且单独的LMP可瞬时诱导这些细胞中Bcl-2表达增加。我们对这些观察结果的解释是,Bcl-2表达的增加不太可能有助于EBV使原代B细胞永生化,并且啮齿动物细胞的转化和LMP介导的细胞毒性均与Bcl-2无关。